lysergic acid diethylamide

GPTKB entity

Statements (83)
Predicate Object
gptkbp:instanceOf Hallucinogen
ergoline derivative
gptkbp:abbreviation LSD
gptkbp:administeredBy gptkb:water
blotter paper
gel tab
sugar cube
gptkbp:aroma odorless
gptkbp:ATCCode N01AX63
gptkbp:CASNumber 50-37-3
gptkbp:category controlled substance
recreational drug
serotonergic psychedelic
tryptamine
gptkbp:chemicalFormula C20H25N3O
gptkbp:color white
gptkbp:discoveredBy gptkb:Albert_Hofmann
gptkbp:discoveredIn 1938
gptkbp:duration_of_effects 8-12 hours
gptkbp:eliminationHalfLife 3-5 hours
gptkbp:excretion renal
gptkbp:first_human_use 1943
gptkbp:first_human_use_by gptkb:Albert_Hofmann
gptkbp:first_human_use_event gptkb:Bicycle_Day
gptkbp:firstSynthesized gptkb:Sandoz_Laboratories
gptkbp:flavor slightly bitter
https://www.w3.org/2000/01/rdf-schema#label lysergic acid diethylamide
gptkbp:IUPACName (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
gptkbp:legalStatus gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
gptkbp:main_effects euphoria
synesthesia
spiritual experiences
visual hallucinations
distorted sense of time
altered thoughts
gptkbp:meltingPoint 80-85°C
gptkbp:metabolism hepatic
gptkbp:molecularWeight 323.43 g/mol
gptkbp:notableEvent central to 1960s counterculture
used in MKUltra experiments
gptkbp:notableFigure gptkb:Stanislav_Grof
gptkb:Aldous_Huxley
gptkb:Ken_Kesey
gptkb:Timothy_Leary
gptkb:Terence_McKenna
gptkb:Richard_Alpert
gptkbp:origin derived from ergot fungus
gptkbp:overdose_risk rare
gptkbp:PubChem_CID gptkb:CHEMBL98
5761
CHEBI:27927
DB04837
gptkbp:relatedTo gptkb:DMT
gptkb:LSD-25
gptkb:ergotamine
psilocybin
mescaline
gptkbp:risk_of_dependence low
gptkbp:routeOfAdministration oral
intravenous
sublingual
gptkbp:sideEffect gptkb:hallucinogen_persisting_perception_disorder
anxiety
paranoia
psychosis
flashbacks
delusions
gptkbp:solubility water-soluble
gptkbp:street_names gptkb:carboxylic_acid
gptkb:Lucy
blotter
dots
windowpane
gptkbp:toxicity very low
gptkbp:UN_drug_control gptkb:Schedule_I_(Convention_on_Psychotropic_Substances)
gptkbp:UNII J94PN8EK2J
gptkbp:used_in psychological theory
psychedelic therapy
recreational drug
gptkbp:bfsParent gptkb:LSD
gptkbp:bfsLayer 5